Showing results (71-80 of 296) with videos related to
Sort By:
Pageof 30
Cancer|December 1, 1984
The hematologic malignancies. Leukemia, lymphoma, and myelomaE J Freireich, M Keating, F Cabanillas, et al.Blood|August 15, 1992
Primary dexamethasone treatment of multiple myelomaR Alexanian, M A Dimopoulos, K Delasalle, et al.British Journal of Haematology|March 1, 1977
The early detection of remission in acute myelogenous leukaemia by in vitro culturesG Spitzer, K A Dicke, K B McCredie, et al.Blood|January 1, 1982
Ploidy and proliferative characteristics in monoclonal gammopathiesJ Latreille, B Barlogie, D Johnston, et al.American Journal of Hematology|November 1, 1994
Effect of low-dose granulocyte-macrophage colony-stimulating factor (LD-GM-CSF) on platelet transfusion-dependent thrombocytopeniaD H Vesole, S Jagannath, L D Glenn, et al.Science (New York, N.Y.)|May 25, 1984
Estrogen receptor analysis by flow cytometryN T Van, M Raber, G H Barrows, et al.Cancer Genetics and Cytogenetics|July 1, 1995
Cytogenetic findings in 200 patients with multiple myelomaJ R Sawyer, J A Waldron, S Jagannath, et al.Cancer Research|June 1, 1976
The effect of adriamycin on the cell cycle traverse of a human lymphoid cell lineB Barlogie, B Drewinko, D A Johnston, et al.Annals of Internal Medicine|December 15, 1991
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myelomaM A Dimopoulos, B Barlogie, T L Smith, et al.Cancer Research|June 1, 1983
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitroB Drewinko, L Y Yang, B Barlogie, et al.Pageof 30